Development of anticancer gene vaccine interact with human papillomavirus oncoprotein inhibition

International Journal of Gynecological Cancer

Volumn 16, Issue 1, 2006, Pages 270-276

  Ahn, W S ^a   Bae, S M ^a   Lee, H J ^a   Kim, Y W ^a,a   Lee, J M ^a   Namkoong, S E ^a   Kim, C K ^b   Jin, H S ^a  

^a The Catholic University of Korea   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Adeno associated virus (AAV); E6 oncoprotein; Human papillomavirus (HPV); Rep 78

Indexed keywords

CANCER VACCINE; MESSENGER RNA; ONCOPROTEIN; PROTEIN E6; REP 78 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CANCER GROWTH; CARCINOMA CELL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; GENETIC TRANSFORMATION; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MOLECULAR CLONING; PARVOVIRUS VECTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VACCINE PRODUCTION; VIRAL GENE THERAPY;

BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CANCER VACCINES; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, VIRAL; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS VACCINES; POLYMERASE CHAIN REACTION; PROBABILITY; SENSITIVITY AND SPECIFICITY; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 33645368323     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00343.x     Document Type: Article

References (27)

1. Durst M Gissmann L Ikenberg H zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 1983 80 3812 5.
2. Cullen AP Reid R Campion M Lorincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991 65 606 12.
3. Hermonat PL. Down-regulation of the human c-fos and c-myc proto-oncogene promoters by adeno-associated virus Rep78. Cancer Lett 1994 81 129 36.
4. Hermonat PL. The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus. Virology 1989 172 253 61.
5. Hermonat PL Plott RT Santin AD Parham GP Flick JT. Adeno-associated virus Rep78 inhibits oncogenic transformation of primary human keratinocytes by a human papillomavirus type 16-ras chimeric. Gynecol Oncol 1997 66 487 94.
6. Hermonat PL Santin AD Batchu RB. The adeno-associated virus Rep78 major regulatory/transformation suppressor protein binds cellular Sp1 in vitro and evidence of a biological effect. Cancer Res 1996 56 5299 304.
7. Mandic A Vujkov T. Human papilloma vaccine as a new was of preventing cervical cancer: a dream or the future? Ann Oncol 2004 15 197 200.
8. Hermonat PL. Inhibition of bovine papillomavirus plasmid DNA replication by adeno-associated virus. Virology 1992 189 329 33.
9. Hermonat PL. Adeno-associated virus inhibits human papilloma virus type 16: a viral infection implicated in cervical cancer. Cancer Res 1994 54 2278 81.
10. Horer M Weger S Butz K Hoppe-Seyler F Geisen C Kleinschmidt JA. Mutational analysis of adeno-associated virus rep protein-mediated inhibition of heterologous and homologous promoters. J Virol 1995 69 5485 96.
11. Zhan D Santin AD Liu Y et al. Binding of the human papillomavirus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition. J Biol Chem 1999 274 31619 24.
12. Su PF Chiang SY Wu CW Wu FY. Adeno-associated virus major Rep78 protein disrupts binding of TATA-binding protein to the p97 promoter of human papillomavirus type 16. J Virol 2000 74 2459 65.
13. Batchu RB Hermonat PL. The trans-inhibitory Rep78 protein of adeno-associated virus binds to TAR region DNA of the human immunodeficiency virus type 1 long terminal repeat. FEBS Lett 1995 367 267 71.
14. Tan SH Gloss B Bernard HU. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res 1992 20 251 6.
15. Taniguchi A Kikuchi K Nagata K Yasumoto S. A cell-type-specific transcription enhancer of type 16 human papillomavirus (HPV 16)-P97 promoter is defined with HPV-associated cellular events in human epithelial cell lines. Virology 1993 195 500 10.
16. Yasumoto S Taniguchi A Sohma K. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region. J Virol 1991 65 2000 9.
17. Stracker TH Cassell GD Ward P et al. The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication. J Virol 2004 78 441 53.
18. Batchu RB Shammas MA Wang JY Munshi NC. Dual level inhibition of E2F-1 activity by adeno-associated virus Rep78. J Biol Chem 2001 276 24315 22.
19. Hermonat PL Santin AD Zhan D. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects. J Hum Virol 2000 3 113 24.
20. Kotin RM Siniscalco M Samulski RJ et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A 1990 87 2211 5.
21. Narasimhan D Collaco R Kalman-Maltese V Trempe JP. Hyper-phosphorylation of the adeno-associated virus Rep78 protein inhibits terminal repeat binding and helicase activity. Biochim Biophys Acta 2002 1576 298 305.
22. Nasseri M Gage JR Lorincz A Wettstein FO. Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7. Virology 1991 18 131 40.
23. Batchu RB Shammas MA Wang JY Munshi NC. Interaction of adeno-associated virus Rep78 with p53: implications in growth inhibition. Cancer Res 1999 59 3592 5.
24. Schmidt M Afione S Kotin RM. Adeno-associated virus type 2 Rep78 induces apoptosis through caspase activation independently of p53. J Virol 2000 74 9441 50.
25. Weger S Hammer E Heilbronn R. Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep78/68 proteins and enhances AAV-2 gene expression. J Gen Virol 2002 83 511 6.
26. Weger S Wendland M Kleinschmidt JA Heilbronn R. The adeno-associated virus type 2 regulatory proteins rep78 and rep68 interact with the transcriptional coactivator PC4. J Virol 1999 73 260 9.
27. Davis MD Wu J Owens RA. Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates. J Virol 2000 74 2936 42.